Biological and Pharmaceutical Bulletin · 2002 · 15 citations · 19 references
MedicinePharmacokineticsPharmacologyDrug MetabolismHepatic PharmacokineticsSteroid BiochemistryCytochrome P450 EnzymesCytochrome P450-mediated MetabolismDrug-metabolizing EnzymesEnzyme InhibitionHepatic MetabolismSteroid MetabolismCompetitive InhibitionCytochrome P450 2C9Cytochrome P450 Enzyme ActivityCytochrome P450 Enzyme InhibitionCytochrome P450 Human Liver MicrosomesCytochrome P450 InhibitionEnzyme ActivityMetabolic Enzyme Inhibition
Effect of nonylphenol on aminopyrine N-demethylase activity, a typical drug-metabolizing enzyme activity, by ten kinds of human hepatic cytochrome P450s (CYP) and on progesterone 17alpha-hydroxylase activity by steroidogenic CYP17 was investigated. When determined at 2 mM substrate concentration, nonylphenol (1 mM) most efficiently inhibited aminopyrine N-demethylation by CYP2C9 and CYP2C19, by 61% and 59%, respectively, followed by CYP2D6, CYP1A2, CYP2C18 and CYP2C8 (46-51%), whereas inhibition of the activities by other CYPs was less than 27%. Additionally, nonylphenol competitively inhibited diclofenac 4'-hydroxylation by CYP2C9 and S-mephenytoin 4'-hydroxylation by CYP2C19 with Ki values of 5.3 and 37 microM, respectively. Furthermore, nonylphenol exhibited a competitive inhibition of progesterone 17alpha-hydroxylase activity by CYP17 with Ki value of 62 microM. These results suggest that nonylphenol inhibits human hepatic CYPs, especially CYP2C9 and CYP2C19, and steroidogenic CYP17 activities.
19
The Carbon Monoxide-binding Pigment of Liver Microsomes
Tsuneo Omura, Ryo Sato · Journal of Biological Chemistry · 1964 · 3.5K citations · Full text
Cytochrome P450: Structure, mechanism, and biochemistry
W. A. PRYOR · Free Radical Biology and Medicine · 1996 · 1.6K citations
Medicine, Biochemistry, Pharmacology +12